Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules.

Frozza RL, Bernardi A, Hoppe JB, Meneghetti AB, Matté A, Battastini AM, Pohlmann AR, Guterres SS, Salbego C.

Mol Neurobiol. 2013 Jun;47(3):1066-80. doi: 10.1007/s12035-013-8401-2.

PMID:
23315270
2.

Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.

Hoppe JB, Coradini K, Frozza RL, Oliveira CM, Meneghetti AB, Bernardi A, Pires ES, Beck RC, Salbego CG.

Neurobiol Learn Mem. 2013 Nov;106:134-44. doi: 10.1016/j.nlm.2013.08.001.

PMID:
23954730
3.

Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer's disease models.

Bernardi A, Frozza RL, Meneghetti A, Hoppe JB, Battastini AM, Pohlmann AR, Guterres SS, Salbego CG.

Int J Nanomedicine. 2012;7:4927-42. doi: 10.2147/IJN.S35333.

4.

Lipid-core nanocapsules improve the effects of resveratrol against Abeta-induced neuroinflammation.

Frozza RL, Bernardi A, Hoppe JB, Meneghetti AB, Battastini AM, Pohlmann AR, Guterres SS, Salbego C.

J Biomed Nanotechnol. 2013 Dec;9(12):2086-104.

PMID:
24266263
5.

Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.

Santos DB, Peres KC, Ribeiro RP, Colle D, dos Santos AA, Moreira EL, Souza DO, Figueiredo CP, Farina M.

Exp Neurol. 2012 Feb;233(2):767-75. doi: 10.1016/j.expneurol.2011.11.036.

6.

Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways.

Simão F, Matté A, Pagnussat AS, Netto CA, Salbego CG.

Eur J Neurosci. 2012 Oct;36(7):2899-905. doi: 10.1111/j.1460-9568.2012.08229.x.

PMID:
22817531
7.

The curry spice curcumin attenuates beta-amyloid-induced toxicity through beta-catenin and PI3K signaling in rat organotypic hippocampal slice culture.

Hoppe JB, Frozza RL, Pires EN, Meneghetti AB, Salbego C.

Neurol Res. 2013 Oct;35(8):857-66. doi: 10.1179/1743132813Y.0000000225.

PMID:
23816368
8.

Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats.

Frozza RL, Bernardi A, Paese K, Hoppe JB, da Silva T, Battastini AM, Pohlmann AR, Guterres SS, Salbego C.

J Biomed Nanotechnol. 2010 Dec;6(6):694-703.

PMID:
21361135
9.

Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus.

Ali T, Yoon GH, Shah SA, Lee HY, Kim MO.

Sci Rep. 2015 Jun 29;5:11708. doi: 10.1038/srep11708.

10.

Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death.

Lin CJ, Chen TH, Yang LY, Shih CM.

Cell Death Dis. 2014 Mar 27;5:e1147. doi: 10.1038/cddis.2014.123.

11.

Resveratrol protects β amyloid-induced oxidative damage and memory associated proteins in H19-7 hippocampal neuronal cells.

Rege SD, Geetha T, Broderick TL, Babu JR.

Curr Alzheimer Res. 2015;12(2):147-56.

PMID:
25654502
12.

Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation.

Hoppe JB, Frozza RL, Horn AP, Comiran RA, Bernardi A, Campos MM, Battastini AM, Salbego C.

J Pineal Res. 2010 Apr;48(3):230-8. doi: 10.1111/j.1600-079X.2010.00747.x.

PMID:
20136701
13.

Cassia obtusifolia seed ameliorates amyloid β-induced synaptic dysfunction through anti-inflammatory and Akt/GSK-3β pathways.

Yi JH, Park HJ, Lee S, Jung JW, Kim BC, Lee YC, Ryu JH, Kim DH.

J Ethnopharmacol. 2016 Feb 3;178:50-7. doi: 10.1016/j.jep.2015.12.007.

PMID:
26674159
15.

Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.

Lahmy V, Meunier J, Malmström S, Naert G, Givalois L, Kim SH, Villard V, Vamvakides A, Maurice T.

Neuropsychopharmacology. 2013 Aug;38(9):1706-23. doi: 10.1038/npp.2013.70.

16.

Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice.

Naert G, Ferré V, Meunier J, Keller E, Malmström S, Givalois L, Carreaux F, Bazureau JP, Maurice T.

Eur Neuropsychopharmacol. 2015 Nov;25(11):2170-82. doi: 10.1016/j.euroneuro.2015.03.018.

PMID:
26381812
17.

Resveratrol protects rats from Aβ-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation.

Huang TC, Lu KT, Wo YY, Wu YJ, Yang YL.

PLoS One. 2011;6(12):e29102. doi: 10.1371/journal.pone.0029102.

18.

Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.

Cai HY, Hölscher C, Yue XH, Zhang SX, Wang XH, Qiao F, Yang W, Qi JS.

Neuroscience. 2014 Sep 26;277:6-13. doi: 10.1016/j.neuroscience.2014.02.022.

PMID:
24583037
19.

SCM-198 inhibits microglial overactivation and attenuates Aβ(1-40)-induced cognitive impairments in rats via JNK and NF-кB pathways.

Hong ZY, Shi XR, Zhu K, Wu TT, Zhu YZ.

J Neuroinflammation. 2014 Aug 19;11:147. doi: 10.1186/s12974-014-0147-x.

Items per page

Supplemental Content

Support Center